540 results match your criteria: "Adult Cystic Fibrosis Centre[Affiliation]"

Studies of microbiota reveal inter-relationships between the microbiomes of the gut and lungs. This relationship may influence the progression of lung disease, particularly in patients with cystic fibrosis (CF), who often experience extraoesophageal reflux (EOR). Despite identifying this relationship, it is not well characterised.

View Article and Find Full Text PDF

Background: This international study aimed to characterise the impact of acute SARS-CoV-2 infection in people with cystic fibrosis and investigate factors associated with severe outcomes. Methods Data from 22 countries prior to 13 December 2020 and the introduction of vaccines were included. It was de-identified and included patient demographics, clinical characteristics, treatments, outcomes and sequalae following SARS-CoV-2 infection.

View Article and Find Full Text PDF

Comparison of innovative communication approaches in nutrition to promote and improve health literacy.

Ulster Med J

May 2022

School of Biomedical Sciences, Ulster University, Cromore Road, Coleraine, Co. Londonderry, Northern Ireland, BT52 1SA, UK.

The translation of scientific evidence into guidelines and advice is a fundamental aspect of scientific communication within nutrition and dietetics. For communication to be effective for all patients, health literacy (HL) must be considered, i.e.

View Article and Find Full Text PDF

The negative impact of chronic rhinosinusitis on the health-related quality of life among adult patients with cystic fibrosis.

J Cyst Fibros

September 2022

Department of Otolaryngology-Head and Neck Surgery, St. Michael's Hospital, Unity Health Toronto, Toronto, ON, Canada; Department of Otolaryngology-Head & Neck Surgery, University of Toronto, Toronto, Ontario, Canada; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada. Electronic address:

Background: With improved survival in cystic fibrosis (CF) patients, it is crucial to evaluate the impact of chronic co-morbidities such as chronic rhinosinusitis (CRS). The objectives were 1) To determine the prevalence of CRS with a large series of CF patients 2) To evaluate the impact of CRS on the Health-Related Quality of Life (HRQoL) of CF patients and 3) To compare CRS-specific, CF-specific and general HRQoL instruments.

Methods: Consecutive CF patients from the Toronto Adult Cystic Fibrosis Centre were recruited between March 2018 and January 2020.

View Article and Find Full Text PDF

Background: VOCAL was an observational study of the effect of long-term ivacaftor on real-world clinical outcomes and healthcare resource utilization (HCRU) in people with cystic fibrosis (pwCF) in Italy, the Netherlands, and the UK.

Methods: pwCF aged ≥6 years with non-G551D-CFTR gating mutations were eligible. Prospective data were collected up to 48 months after enrollment; retrospective data were collected to ensure that 12 months of pre-ivacaftor data were available.

View Article and Find Full Text PDF

The black yeast has been isolated in respiratory samples from people with cystic fibrosis (CF). However, adequate detection may require longer incubation periods than the current UK national standard for CF respiratory samples. Furthermore, it is unclear whether isolation of is associated with poorer clinical outcomes in CF.

View Article and Find Full Text PDF

There were respiratory consultant post vacancies in 82% of surveyed UK hospitals in 2021. Understanding respiratory trainees' career intentions is vital to plan and train a future respiratory workforce. In 2020, the British Thoracic Society surveyed trainee members (n=144) to assess career plans and perceived barriers and facilitators when applying for consultant posts.

View Article and Find Full Text PDF

Lung transplantation in the COVID-19 Era: A multi-faceted challenge.

Respir Med Res

May 2022

Paris-Saclay University, School of Medicine, Le Kremlin-Bicêtre, France; INSERM UMR_S 999, Pulmonary Hypertension: Pathophysiology and Novel Therapies Unit, Marie Lannelongue Hospital, Paris Saint-Joseph Hospital Group, Le Plessis-Robinson, France; Marie Lannelongue Hospital, Paris Saint-Joseph Hospital Group, Department of transplantation and thoracic and vascular surgery, Pulmonary Hypertension National Referral Centre, Le Plessis Robinson, France.

View Article and Find Full Text PDF

The rise of antimicrobial-resistant (AMR) bacteria is a global health emergency. One critical facet of tackling this epidemic is more rapid AMR diagnosis in serious multidrug-resistant pathogens like Pseudomonas aeruginosa. Here, we designed and then validated two multiplex quantitative real-time PCR (qPCR) assays to simultaneously detect differential expression of the resistance-nodulation-division efflux pumps MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprM, the AmpC β-lactamase, and the porin OprD, which are commonly associated with chromosomally encoded AMR.

View Article and Find Full Text PDF

Exophiala dermatitidis is increasingly isolated from cystic fibrosis (CF) respiratory samples. The decision to treat is hampered by limited evidence demonstrating the clinical significance of isolating E. dermatitidis.

View Article and Find Full Text PDF
Article Synopsis
  • * New CFTR modulator therapies have shown promise in improving clinical outcomes by restoring CFTR function and enhancing airway defense mechanisms.
  • * The review explores the impact of these modulators on airway infections in CF, including their effects on infection susceptibility and the potential for preventing chronic lung infections, though long-term effects are still not fully understood.
View Article and Find Full Text PDF

Objective: Imaging represents an important noninvasive means to assess cystic fibrosis (CF) lung disease, which remains the main cause of morbidity and mortality in CF patients. While the development of new imaging techniques has revolutionised clinical practice, advances have posed diagnostic and monitoring challenges. The authors aim to summarise these challenges and make evidence-based recommendations regarding imaging assessment for both clinicians and radiologists.

View Article and Find Full Text PDF

Safety of mRNA-based vaccines against SARS-CoV-2 in people with cystic fibrosis aged 12 years and over.

J Cyst Fibros

May 2022

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Italy; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Cystic Fibrosis Centre, Milan, Italy. Electronic address:

View Article and Find Full Text PDF

CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19.

Ulster Med J

January 2022

School of Medicine, Dentistry and Biomedical Sciences, The Wellcome-Wolfson Institute for Experimental Medicine, Queen's University, 97 Lisburn Road, Belfast BT9 7BL, Northern Ireland, UK.

View Article and Find Full Text PDF

Managing Pulmonary Infection in Adults With Cystic Fibrosis: Adult Cystic Fibrosis Series.

Chest

July 2022

Manchester Adult Cystic Fibrosis Centre, Manchester University NHS Foundation Trust, Manchester, England; Division of Infection, Immunity and Respiratory Medicine, University of Manchester, Manchester, England. Electronic address:

Cystic fibrosis (CF) is characterized by chronic airway infection and progressive respiratory decline. Historically, a narrow spectrum of bacterial pathogens was believed to comprise the bulk of respiratory infections in CF, with Haemophilus influenzae and Staphylococcus aureus dominating childhood infections, and Pseudomonas aeruginosa or, less commonly, a member of the Burkholderia cepacia complex becoming the dominant infecting organism in adulthood. Today, the landscape is changing for airway infection in CF.

View Article and Find Full Text PDF

Interrupting the transmission of airborne (<≈5 µm) respiratory pathogens indoors is not a new challenge, but it has attracted unprecedented interest due to the COVID-19 pandemic during 2020-2021. However, bacterial respiratory pathogens with known or potential airborne transmission account for an appreciable proportion of the communicable disease burden globally. We aimed to systematically review quantitative, laboratory-based studies of air disinfection techniques for airborne respiratory bacteria.

View Article and Find Full Text PDF
Article Synopsis
  • Cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) lead to frequent lung flare-ups, impacting patients' quality and length of life, but the role of specific bacteria in airway infections is not well understood.
  • Researchers developed a real-time PCR test to quickly identify and quantify certain bacteria from respiratory samples, validating its use on various cultures, including those from CF and COPD patients.
  • Whole-genome sequencing revealed a diversity of bacterial species in patients' lungs, with higher antibiotic resistance found in CF isolates, highlighting the need for better understanding of these bacteria in lung health and disease.
View Article and Find Full Text PDF

Adherence to medication in long-term conditions is around 50%. The key components of successful interventions to improve medication adherence remain unclear, particularly when examined over prolonged follow-up periods. Behaviour change theories are increasingly interested in the utility of habit formation for the maintenance of health behaviour change, but there is no documentation on how habit has been conceptualised in the medication adherence intervention literature, or what effect the key technique identified in habit formation theory (context dependent repetition) has in these studies.

View Article and Find Full Text PDF

Standards of care guidance for sweat testing; phase two of the ECFS quality improvement programme.

J Cyst Fibros

May 2022

Cystic Fibrosis Centre, Department of Gastroenterology and Transplantation, United Hospitals, Ancona, Italy.

More than five decades after the introduction of the quantitative pilocarpine iontophoresis technique, surveys still highlight inconsistencies in the performance and reporting of sweat tests in Europe. The sweat test remains key for the Cystic Fibrosis (CF) diagnostic pathway for all age groups, as it reflects the basic pathophysiological defect in the sweat gland. It is also critical following newborn screening as a confirmatory diagnostic step.

View Article and Find Full Text PDF

Background: Cystic fibrosis-related liver disease (CFLD) is the leading cause of death in cystic fibrosis (CF), after pulmonary disease. To improve identification and management of this condition requires an understanding of the underlying disease mechanism.

Aims: This review summarises the current understanding of CFLD epidemiology, pathology, diagnosis and management.

View Article and Find Full Text PDF

The genetic multisystem condition cystic fibrosis (CF) has seen a paradigm shift in therapeutic approaches within the past decade. Since the first clinical descriptions in the 1930s, treatment advances had focused on the downstream consequences of a dysfunctional cystic fibrosis transmembrane conductance regulator (CFTR) chloride ion channel. The discovery of the gene that codes for CFTR and an understanding of the way in which different genetic mutations lead to disruption of normal CFTR function have led to the creation and subsequent licensing of drugs that target this process.

View Article and Find Full Text PDF